ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1917

Tubulointerstitial Inflammation Predicts Outcomes in Lupus Nephritis

Charles Oshinsky1, Mariam Siddiqui 2, Vladimir Liarski 3, Anthony Chang 3, Marcus Clark 4 and Kichul Ko 3, 1University of Chicago, Department of Internal Medicine, Chicago, 2Northwestern Memorial Hospital, Chicago, 3University of Chicago, Chicago, 4University of Chicago, Chicago, IL

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: Lupus nephritis, tubulointerstitial inflammation and renal survival

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 11, 2019

Title: 4M120: SLE – Clinical IV: Lupus Nephritis (1914–1919)

Session Type: ACR Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: Lupus nephritis (LuN) causes significant morbidity and mortality, but predicting which patients will progress still remains imprecise. Current classification schema for LuN and its treatment are based exclusively or primarily on the glomerulus. Multiple studies have found that such classification schemes inconsistently predict outcomes, whereas tubulointerstitial inflammation (TII) has been shown to associate with poor renal survival. However, long-term data from a cohort with mostly African American (AA) patients with severe TII are still lacking. We aimed to determine the association between TII and long-term renal survival in LuN, and at-biopsy factors associated with moderate to severe TII.

Methods: Retrospective data from LuN subjects who had native kidney biopsies done from 2003 through 2014 were collected. Only those with at least 2 years of follow-up from the time of biopsy were included for analysis. Subjects were classified by International Society of Nephrology/Renal Pathology Society (ISN/RPS) criteria, and Class III and IV cases were combined into a proliferative class for analysis. TII was scored semi-quantitatively through light and immunofluorescence (CD45) microscopy by a blinded pathologist, and given scores from 0 – 3: 0 (< 10% of involvement, minimal), 1 (10 – 25%, mild), 2 (26 – 50%, moderate) and 3 ( >50%, severe). Bivariate comparisons and multivariate logistic regression (MLR) analysis were performed to determine at-biopsy factors associated with moderate to severe TII. Renal survival analyses were done though Kaplan – Meier technique with time to end-stage renal disease (ESRD) with curves compared through the log-rank test.

Results: Among 122 subjects, 75.4% were AA, 84.4% were female, and 73.0% had proliferative LuN. The median follow-up period was 5.3 years (interquartile range 3.4 – 8.4 years). 60 subjects had moderate to severe TII, and they had higher percent of AA (91.7 vs 59.7%, p < 0.0001), higher median creatinine (1.5 vs 0.7 mg/dL, p < 0.0001), higher degree of proteinuria (3.8 g/day vs 1.8 g/day, p < 0.0001), and higher glomerular activity index (p = 0.02) and chronicity index (CI, both glomerular [p = 0.0001] and tubulointerstitial [p < 0.0001]) than those with minimal to mild TII. MLR analysis showed that moderate to severe TII was only associated with AA ethnicity (Odds Ratio [OR] 5.38, p = 0.028) and tubulointerstitial CI (OR 3.85, p = 0.001) but not with proliferative class or glomerular CI. Renal survival analysis found that subjects with moderate to severe TII had worse renal survival (approximately 50% with ESRD by 4th year) compared to those with minimal to mild TII (hazard ratio 5.01, p < 0.0001). There was no renal survival difference based on the presence of proliferative LuN (p = 0.2).

Conclusion: Higher degree of TII predicted worse renal survival, whereas ISN/RPS classification was not prognostic. Only AA ethnicity and tubulointerstitial CI were associated with moderate to severe TII at biopsy.

Higher degree of tubulointerstitial inflammation predicted worse renal survival

The ISN/RPS classification , stratified by proliferative -class III and class IV- vs nonproliferative, does not predict renal survival


Disclosure: C. Oshinsky, None; M. Siddiqui, None; V. Liarski, None; A. Chang, Alexion, 5, 8, GlaxoSmithKline, 5, Amicus, 5; M. Clark, None; K. Ko, None.

To cite this abstract in AMA style:

Oshinsky C, Siddiqui M, Liarski V, Chang A, Clark M, Ko K. Tubulointerstitial Inflammation Predicts Outcomes in Lupus Nephritis [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/tubulointerstitial-inflammation-predicts-outcomes-in-lupus-nephritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/tubulointerstitial-inflammation-predicts-outcomes-in-lupus-nephritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology